Owners and management
CVR: 44958821
Not available
Mikkel Wandahl Pedersen (25-33,32%), AB BIO GmbH (66,66-89,99%)
CVR · view owners
Axel Johannes Behrens
CVR · view management
Active
Founded 9 July 2024
CVR · view overview
1 employee
CVR · 2026
Director registered: Axel Johannes Behrens
CVR · 10/06/2026
View the full event history
Analona Therapeutics ApS is a Danish company of the type Anpartsselskab based in Nykøbing F, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Axel Johannes Behrens. The company is owned by Mikkel Wandahl Pedersen and AB BIO GmbH. The company has 1 employee (2026).
Selskabets formål er at opdage og udvikle nye lægemidler til behandling af alvorlige sygdomme med fokus på bugspytkirtelkræft.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Analona Therapeutics ApS is 44958821.
Analona Therapeutics ApS is owned by Mikkel Wandahl Pedersen and AB BIO GmbH.
The management of Analona Therapeutics ApS consists of Axel Johannes Behrens.
Analona Therapeutics ApS had 1 employee in 2026 according to the Danish CVR register.
Analona Therapeutics ApS was founded on 9 July 2024.
Analona Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Claim this page to add your logo and social links. Free to get started.
Address changed to Herningvej 34, 4800 Nykøbing F (September 9, 2026).
Analona Therapeutics ApS has published its interim report for the period July 9, 2024 – December 31, 2025.
As of June 10, 2026, Axel Johannes Behrens is registered as adm. dir. of Analona Therapeutics ApS.
As of June 9, 2026, Gert Mads Bolwig has stepped down as adm. dir. of Analona Therapeutics ApS.
As of June 9, 2026, Axel Johannes Behrens has stepped down as director of Analona Therapeutics ApS.
As of June 1, 2026, Mikkel Wandahl Pedersen has stepped down as director of Analona Therapeutics ApS.
As of October 1, 2024, Gert Mads Bolwig is registered as adm. dir. of Analona Therapeutics ApS.
As of July 9, 2024, Mikkel Wandahl Pedersen is registered as director of Analona Therapeutics ApS.
As of July 9, 2024, Axel Johannes Behrens is registered as director of Analona Therapeutics ApS.
As of July 9, 2024, Mikkel Wandahl Pedersen is registered as an owner of Analona Therapeutics ApS with an ownership share of 25%.
As of July 9, 2024, is registered as an owner of Analona Therapeutics ApS with an ownership share of 66%.
Analona Therapeutics ApS was founded on July 9, 2024.
Companies in the same industry and area
CVR 45363155
CVR 43475576
CVR 43950606
CVR 45476502
CVR 13373132
